ภาษาไทย Español Português 한국어 简体中文 繁體中文 日本語 Tiếng Việt Bahasa Indonesia Монгол ئۇيغۇر تىلى العربية Русский हिन्दी
AGBK IPO: Launch Timeline, Expected Pricing, Valuation
AGBK IPO: Launch Timeline, Expected Pricing, Valuation
2026-02-09
AGBK IPO targets a Feb 11, 2026 debut, pricing at $15-$18; investors weigh Agibank's growth, valuation, and INSS risk.
FAANG Stocks Outlook: AI Capex and 2026 Rebound Signals
FAANG Stocks Outlook: AI Capex and 2026 Rebound Signals
2026-02-09
AI capex is reshaping FAANG valuations. Learn what is driving the pullback and what a 2026 rebound would likely require.
Why EL Stock Fell After Earnings: Tariffs, Costs, High Bar
Why EL Stock Fell After Earnings: Tariffs, Costs, High Bar
2026-02-06
EL stock fell after earnings despite a beat and a higher outlook. Tariff headwinds, restructuring costs, and a high bar for guidance drove the selloff.
Is the Stock Market Going to Crash in 2026? Expert Analysis
Is the Stock Market Going to Crash in 2026? Expert Analysis
2026-02-06
Market crash fears are rising in 2026. Here is a view of the biggest risks, key indicators to watch, and whether the stock market will crash this year.
Most Expensive Stocks In The World: Top 10 By Share Price
Most Expensive Stocks In The World: Top 10 By Share Price
2026-02-06
Discover the 10 most expensive stocks in the world in 2026, including Berkshire Hathaway and Lindt & Sprüngli. See their prices, industries, exchanges, and why these shares trade at such extreme levels.
What is Sell America and Why Did It Happen
What is Sell America and Why Did It Happen
2026-02-06
Sell America trade explained: why investors rotate from US assets, where money flows next, and key signals and risks for traders.
Why Oracle (ORCL) Stock Is Falling? Reasons, Support Levels, Next Move
Why Oracle (ORCL) Stock Is Falling? Reasons, Support Levels, Next Move
2026-02-06
Sell America trade: why USD, stocks & Treasuries can fall together, and 5 clear signals plus practical hedges traders can use.
NVIDIA (NVDA) Stock Falls To A Year-To-Date Low, Why and What’s Next
NVIDIA (NVDA) Stock Falls To A Year-To-Date Low, Why and What’s Next
2026-02-05
NVDA’s 2026 YTD low reflects discount-rate and policy-risk repricing; AI demand strong, but cycle length, margins, China in focus.
Why Is Nvidia Dropping and If the Down-trend Will Continue
Why Is Nvidia Dropping and If the Down-trend Will Continue
2026-02-05
Nvidia is dropping now. Discover the real reasons behind the fall and whether this down-trend could deepen or reverse as market pressure intensifies.
Why AMD Stock Is Dropping After Q4 Earnings: Valuation, Profit-Taking
Why AMD Stock Is Dropping After Q4 Earnings: Valuation, Profit-Taking
2026-02-05
Learn why AMD stock sold off: one-time MI308 boosts, China revenue drop in Q1 guidance, and margins normalizing near 55%.
Why Intuit (INTU) Stock Is Dropping, Ahead Of Feb 26 Earnings
Why Intuit (INTU) Stock Is Dropping, Ahead Of Feb 26 Earnings
2026-02-04
INTU slid ahead of Feb 26 earnings as valuation resets, tax-season uncertainty, AI moat worries and fintech-like financing risks rise.
Forgent Power Solutions: FPS IPO Launch Date, Key Risks, And More
Forgent Power Solutions: FPS IPO Launch Date, Key Risks, And More
2026-02-04
FPS IPO watch: expected timing, pricing range, valuation math, backlog signals, and the key risks that can re-rate the stock.
Why PayPal Stock Fell After Earnings: Weak Outlook, CEO Change
Why PayPal Stock Fell After Earnings: Weak Outlook, CEO Change
2026-02-04
PayPal stock plunged after earnings revenue, and EPS missed, a weaker 2026 outlook, and a sudden CEO change. Here are the key drivers and levels to watch.
AREB Stock Split: 1-for-20 Reverse Split Explained
AREB Stock Split: 1-for-20 Reverse Split Explained
2026-01-30
AREB stock split set for Feb 2, 2026: what the 1-for-20 reverse split changes for shares, price, and AREBW warrants.
UnitedHealth (UNH) Stock Falls: Key Levels and What’s Next
UnitedHealth (UNH) Stock Falls: Key Levels and What’s Next
2026-01-29
UnitedHealth (UNH) stock falls sharply: key support and resistance levels, RSI and moving averages, plus a clear fundamental outlook on medical cost pressure, Medicare Advantage rates, earnings guidance, valuation, and what could drive the next move.